comparemela.com

Latest Breaking News On - Biosenic - Page 1 : comparemela.com

BioSenic raises €500,000 in private placement of new shares

PRESS RELEASE – REGULATED INFORMATION NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED.

France generalMont saint guibertWaals gewestSouth africaMichelle boxallGhislaine gasparettoBanque delubac cieGestys santSeitosei actifinBelgian code on companiesBiosenic groupInternational media enquiriesIb communicationsEuronext brusselsEuronext parisBelgian code

BioSenic S A : Information on the total number of voting

Information on the total number of voting rights and shares Mont-Saint-Guibert, Belgium, September 1, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and.

Mont saint guibertWaals gewestFrance generalSeitosei actifinNeil hunter michelle boxallGhislaine gasparettoNeither the companyInternational media enquiriesIb communicationsEuronext brusselsGraft versus host diseaseLouvain la neuve science parkMesenchymal stromal cellsChief executiveMedia enquiriesFrench investor enquiries

BioSenic S A : Information on the total number of voting rights and shares Seite 1

03.07.2023 - REGULATED INFORMATION Mont-Saint-Guibert, Belgium, July 3rd, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the innovative company addressing unmet medical needs in in the areas of innate immunity, inflammation and . Seite 1

France generalMont saint guibertWaals gewestEuronext brusselsBelgian lawIosenic sa

BioSenic puts Phase IIb ALLOB trial on hold

INSIDE INFORMATION Prior efficacy unmatched but excellent safety profile confirmed, timing of ALLOB administration for optimal bone repair to.

Mont saint guibertWaals gewestFrance generalLieven huysseNeil hunter michelle boxallGhislaine gasparettoInternational media enquiriesIb communicationsEuronext brusselsChief medical officerHost diseaseFull study populationPer protocolChief executive officerArsenic trioxideSystemic sclerosis

BioSenic provides update regarding current license agreement with Phebra

INSIDE INFORMATION Maintenance of the license isnow subject to the launch of the OATO Phase III before May 2024instead of 31 May 2023 Parties also…

France generalMont saint guibertWaals gewestSeitosei actifinNeil hunter michelle boxallAnnie florence loyerBert bouserieGhislaine gasparettoBiosenic groupInternational media enquiriesIb communicationsPhebra pty ltdEuronext brusselsGraft versus host diseaseSystemic sclerosisSystemic lupus erythematosus

vimarsana © 2020. All Rights Reserved.